A groundbreaking lung cancer vaccine will be tested on humans from summer 2026, with British scientists working on jabs for ...

Data from IDeate-Lung01 trial will be presented at upcoming IASLC 2025 World Conference on Lung Cancer First Breakthrough Therapy Designation for Daiichi Sankyo and Merck’s ifinatamab deruxtecan based ...

The MarketWatch News Department was not involved in the creation of this content. Designation granted for gotistobart (BNT316/ONC392) for the treatment of patients with squamous non-small cell lung ...

Scientists in the UK have developed a breakthrough blood test that can detect lung cancer one cell at a time using FT-IR microspectroscopy. The technique identifies circulating tumour cells by their ...

Merck MRK announced that the FDA has granted the Breakthrough Therapy designation (BTD) to its B7-H3-directed DXd antibody-drug conjugate (ADC), ifinatamab deruxtecan (I-DXd), for treating adult ...

A team of researchers from three different institutions from the UK have come up with a technique to detect and monitor the ...

WILMINGTON, DEL. (November 14, 2025) – In a major step forward for cancer care, researchers at ChristianaCare’s Gene Editing Institute have shown that disabling the NRF2 gene with CRISPR technology ...

Eli Lilly has won a key U.S. Food and Drug Administration designation for its investigational drug olomorasib in certain lung cancer patients. Eli Lilly on Thursday said the FDA granted ...

Study in Molecular Therapy Oncology shows gene editing restores drug sensitivity by targeting NRF2, with potential across multiple tumor types In a major step forward for cancer care, researchers at ...

Georgia Tech and Vanderbilt researchers have built the first lung-on-a-chip with a working immune system, a breakthrough with the potential to reshape how we study disease, move beyond animal testing, ...